In both T1DM and T2DM, GIP infusion markedly decreases circulating CTX levels regardless of glycemic state, suggesting a direct inhibitory action on osteoclast activity that is largely independent of insulin. This evidence concerns the gene GIP and type 1 diabetes mellitus.